Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C.

World J Gastrointest Oncol. 2014 May 15;6(5):104-11. doi: 10.4251/wjgo.v6.i5.104. Review.

2.

Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Jeffery M, Hickey BE, Hider PN, See AM.

Cochrane Database Syst Rev. 2016 Nov 24;11:CD002200. Review.

PMID:
27884041
3.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

4.

Follow-up of patients with curatively resected colorectal cancer: a practice guideline.

Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C; Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Cancer. 2003 Oct 6;3:26. Review.

5.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

6.

Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Jeffery M, Hickey BE, Hider PN.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002200. Review. Update in: Cochrane Database Syst Rev. 2016 Nov 24;11:CD002200.

PMID:
17253476
7.

Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Jeffery GM, Hickey BE, Hider P.

Cochrane Database Syst Rev. 2002;(1):CD002200. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD002200.

PMID:
11869629
8.

Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis.

Pita-Fernández S, Alhayek-Aí M, González-Martín C, López-Calviño B, Seoane-Pillado T, Pértega-Díaz S.

Ann Oncol. 2015 Apr;26(4):644-56. doi: 10.1093/annonc/mdu543. Epub 2014 Nov 19. Review.

PMID:
25411419
9.

A prospective analysis of false positive events in a National Colon Cancer Surveillance Program.

Augestad KM, Norum J, Rose J, Lindsetmo RO.

BMC Health Serv Res. 2014 Mar 27;14:137. doi: 10.1186/1472-6963-14-137.

10.

Follow-up after curative resection of colorectal cancer: a meta-analysis.

Tjandra JJ, Chan MK.

Dis Colon Rectum. 2007 Nov;50(11):1783-99. Review.

PMID:
17874269
11.

Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.

Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D; FACS Trial Investigators.

JAMA. 2014 Jan 15;311(3):263-70. doi: 10.1001/jama.2013.285718.

PMID:
24430319
12.

The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.

Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.

Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350. Review.

13.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

14.

Optimal delivery of colorectal cancer follow-up care: improving patient outcomes.

Jorgensen ML, Young JM, Solomon MJ.

Patient Relat Outcome Meas. 2015 May 18;6:127-38. doi: 10.2147/PROM.S49589. eCollection 2015. Review.

15.

[Surveillance after curative resection for colorectal cancer].

Hashiguchi Y, Ueno H, Kobayashi H, Ishiguro M, Mochizuki H.

Nihon Geka Gakkai Zasshi. 2007 May;108(3):125-30. Japanese.

PMID:
17533949
16.

Intensified surveillance after surgery for colorectal cancer significantly improves survival.

Laubert T, Bader FG, Oevermann E, Jungbluth T, Unger L, Roblick UJ, Bruch HP, Mirow L.

Eur J Med Res. 2010 Jan 29;15(1):25-30.

17.
18.

Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort study.

Castells A, Bessa X, Daniels M, Ascaso C, Lacy AM, García-Valdecasas JC, Gargallo L, Novell F, Astudillo E, Filella X, Piqué JM.

Dis Colon Rectum. 1998 Jun;41(6):714-23; discussion 723-4.

PMID:
9645739
19.

Intensive surveillance following curative treatment of colorectal cancer allows effective treatment of recurrence even if limited to 4 years.

Adams K, Higgins L, Beazley S, Papagrigoriadis S.

Int J Colorectal Dis. 2015 Dec;30(12):1677-84. doi: 10.1007/s00384-015-2356-x. Epub 2015 Aug 30.

PMID:
26320020
20.

The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis.

Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, Jenkins JT.

Ann Surg Oncol. 2014 Nov;21(12):3938-46. doi: 10.1245/s10434-014-3815-2. Epub 2014 May 28. Review.

PMID:
24866438

Supplemental Content

Support Center